About Intercell
Intercell is a company based in Vienna (Austria) founded in 1998 by Arunabh Varma.. Intercell has raised $78.62 million across 2 funding rounds from investors including Global Life Science Ventures. Intercell has completed 1 acquisition, including Iomai Corporation. Intercell operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter Vienna, Austria
- Founders Arunabh Varma
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$78.62 M (USD)
in 2 rounds
-
Latest Funding Round
$44.98 M (USD), Series B
Feb 23, 2011
-
Investors
Global Life Science Ventures
& 1 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
N/A
(Dec 17, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Intercell
Intercell has successfully raised a total of $78.62M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $44.98 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $45.0M
-
First Round
First Round
(17 Jul 2003)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2011 | Amount | Series B - Intercell | Valuation |
investors |
|
| Jul, 2003 | Amount | Series A - Intercell | Valuation | Global Life Science Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Intercell
Intercell has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Global Life Science Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & late stage life sciences focused VC firm funding companies in the US and Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Intercell
Intercell has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Iomai Corporation. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Vaccines and immune stimulants are developed via needle-free transcutaneous immunization.
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Intercell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intercell Comparisons
Competitors of Intercell
Intercell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Developer of biologics to treat hepatitis B infection
|
|
| domain | founded_year | HQ Location |
Developer of computationally designed VLP vaccines for treating multiple infections
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intercell
Frequently Asked Questions about Intercell
When was Intercell founded?
Intercell was founded in 1998 and raised its 1st funding round 5 years after it was founded.
Where is Intercell located?
Intercell is headquartered in Vienna, Austria.
Who is the current CEO of Intercell?
Arunabh Varma is the current CEO of Intercell. They have also founded this company.
Is Intercell a funded company?
Intercell is a funded company, having raised a total of $78.62M across 2 funding rounds to date. The company's 1st funding round was a Series A of $33.64M, raised on Jul 17, 2003.
What does Intercell do?
Founded in 1998 in Vienna, Austria, Intercell focused on biotechnology within the infectious disease sector. Vaccines, antigens, and adjuvants were developed for various applications, with a Japanese encephalitis vaccine already marketed. Operations centered on research and production until the 2012 acquisition by Vivalis for 174 million, after which the combined entity was renamed Valneva.
Who are the top competitors of Intercell?
Intercell's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
How many acquisitions has Intercell made?
Intercell has made 1 acquisition, including Iomai Corporation.
Who are Intercell's investors?
Intercell has 1 investor. Key investors include Global Life Science Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.